Create
Query
event_store.db
—
events
actions
approvals
artifacts
commitments
constraints
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row 991 in events
seq
Primary key.
INTEGER
id
evt_514ffe4eaf08
TEXT NOT NULL
kind
signal_ingest
TEXT NOT NULL
ts
2026-04-07T23:37:48.739531+00:00
TEXT NOT NULL
actor
daemon:signal_enrichment
TEXT
subject_entity_ids
[]
TEXT
payload
{"created_at":"2026-04-07T23:23:54.391414+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:45301c53f034bb9d","evidence_event_ids":["evt_91dab5db0956"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-040179.txt","as_of":"2026-04-07T23:23:54.391414+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-040179.txt","company":"Unicycive Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-040179.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_25960cb33ed9047d","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-040179.txt","content_type":"text/plain","enriched_at":"2026-04-07T23:37:48.739489+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-040179.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-040179.txt","source_event_id":"evt_91dab5db0956","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"1f1e2a985770511c","kind":"sec_filing","published_at":"20260406","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["April 6, 2026","2026-04-06","2026-04-07"],"entities":[{"asset_class":"equity","name":"Unicycive Therapeutics, Inc.","relevance":"high","symbol":"UNCY","type":"issuer"},{"asset_class":"person","name":"Gaurav Aggarwal","relevance":"high","symbol":"","type":"person"},{"asset_class":"governance","name":"Board of Directors","relevance":"medium","symbol":"","type":"governance_body"}],"event_type":"other","information_gaps":["No prior known state is provided in the signal, so the specific 'delta vs prior' cannot be quantified beyond stating this 8-K discloses the resignation.","The filing does not specify whether a replacement director was appointed.","No additional 8-K items (beyond the resignation disclosure) are included in the provided text."],"key_facts":["Form type: 8-K (Current Report).","Date of report / earliest event reported: April 6, 2026.","The company reported that on April 6, 2026, Gaurav Aggarwal resigned from the Board of Directors.","The filing states the resignation was not a result of any disagreement with the company or its management or Board on any matter related to the company\u2019s operations, policies, or practices.","The company expressed gratitude to Dr. Aggarwal for serving on the Unicycive Board of Directors."],"numeric_claims":[],"primary_claim":"On April 6, 2026, director Gaurav Aggarwal resigned from Unicycive Therapeutics, Inc.\u2019s Board of Directors, and the resignation was not due to any disagreement with the company or its management or board.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Unicycive Therapeutics, Inc. filed a Form 8-K on April 6, 2026 to report the resignation of director Gaurav Aggarwal from its Board of Directors. The filing states the resignation was not due to any disagreement with the company or its management/board.","topics":["SEC filing","Form 8-K","director resignation","corporate governance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 Unicycive Therapeutics, Inc. \u00b7 Filed 20260406","ticker":"UNCY","tickers":["UNCY"],"title":"UNCY filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1766140/0001213900-26-040179.txt"}}
TEXT NOT NULL
source_ref
candidate:sc_25960cb33ed9047d
TEXT
confidence
REAL (default 0.0
dedupe_key
signal_enriched:discovery_sec_filing_delta:45301c53f034bb9d
TEXT
episode_id
NULL
TEXT
created_at
2026-04-07T23:37:48.739578+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel